BiotechTube
Home/Dermata Therapeutics/David F. Hale
DF

David F. Hale

Executive Chairman

Dermata Therapeutics

Therapeutic Areas

DermatologyAesthetic Medicine

Dermata Therapeutics Pipeline

DrugIndicationPhase
DMT310Moderate-to-Severe AcnePhase 2b
DMT410Primary Axillary HyperhidrosisPhase 1b

Leadership Team at Dermata Therapeutics

GT
Gerald T. Proehl
Chairman, President & Chief Executive Officer
View full Dermata Therapeutics profile